Irish association names president
This article was originally published in Scrip
Lilly's managing director in Ireland, Dr Gerald Farrell, has been named president of the Irish Pharmaceutical Healthcare Association. He has held various positions in new product planning, market research, sales management and manufacturing both in the UK and Ireland. The IPHA represents the research-based pharmaceutical industry in Ireland. Dr Farrell's term will last for two years.
You may also be interested in...
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.